Dyadic Applied BioSolutions
Business Services · Florida, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1044 N Us Hwy 1 Ste 201, Jupiter, Florid...Phone Number
(561) 743-8333Website
www.dyadic.comRevenue
<$5 MillionStock Symbol
DYAIIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
2
1
1
1
About Dyadic Applied BioSolutions
Dyadic International is a global biotechnology company founded in 1979 that develops a biopharmaceutical gene expression platform based on the fungus Thermothelomyces heterothallica, named C1. This innovative technology enables the development and manufacture of low-cost proteins for biologic vaccines and drugs. The C1 platform aims to speed up development, lower production costs, and improve performance of various therapeutic products including virus-like particles, antigens, monoclonal antibodies, and other proteins. Dyadic focuses on research and development collaborations and licensing arrangements to leverage its technologies in biopharmaceutical manufacturing. The company works to bring biologic products to market more efficiently, potentially improving healthcare accessibility through its proprietary fungal expression system.Explore more
Dyadic Applied BioSolutions Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Dyadic Applied BioSolutions your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Dyadic Applied BioSolutions
Check out if Dyadic Applied BioSolutions is spiking on competitors!
Check if Dyadic Applied BioSolutions has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Dyadic Applied BioSolutions launches new products
Website visits: Recent activity has been detected on your website
Dyadic Applied BioSolutions, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Dyadic Applied BioSolutions recently announced quarterly report
Click to see if Dyadic Applied BioSolutions had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Dyadic Applied BioSolutions has new funding data
Recommended Actions
Reach out to Masked Content who joined Dyadic Applied BioSolutions as Masked Content
Find more new buyers
Compare Similar Companies to Dyadic Applied BioSolutions
Compare insights from companies similar to Dyadic Applied BioSolutions, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Dyadic Applied BioSolutions is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Dyadic Applied BioSolutions is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Dyadic Applied BioSolutions.
Dyadic Applied BioSolutions financials insights
Gather financial insights about Dyadic Applied BioSolutions, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
Dyadic Applied BioSolutions Tech Stack
A closer look at the technologies used by Dyadic Applied BioSolutions
Most Recent Scoops
Partnership
Dyadic Applied BioSolutions has partnered with Integrated Biotherapeutics to serve as the distribution partner for certain DIAD products, expanding the company's commercial reach in the market.
Partnership, Business Development
Project
intends to appeal the Nasdaq delisting determination, which will allow the company's common stock to continue trading on Nasdaq during the appeal process.
Partnership
Dyadic Applied BioSolutions has entered into biopharmaceutical collaborations with Scripps Research and the Gates Foundation to advance several programs and further validate the capability and versatility of the company's production technologies.
Partnership, Pharmaceuticals
Person-Based
Dyadic Applied BioSolutions News & Media
Dyadic Expands IP Protection and Business Development Activities in Japan
Dyadic Expands IP Protection and Business Development Activities in JapanDyadic Applied Biosolutions - June Update: C1 Platform Activity and Protein & Enzyme Programs Overview
Highlights from DYAI's recent company updates on protein expression technology and partnerships Dyadic Applied BioSolutions (NASDAQ:DYAI) FLORIDA CITY, FL, UNITED STATES, June 22, 2026 /EINPresswire.com/ -- Most small-cap biotechs hinge on a single …Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial Adoption
Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial AdoptionDyadic and Scripps Research Collaborate on Rapid-Response Hantavirus Antibody and Vaccine Development
Dyadic and Scripps Research Collaborate on Rapid-Response Hantavirus Antibody and Vaccine Development
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Dyadic Applied BioSolutions
Sign Up For FreeTo access detailed company insights
Dyadic International is a global biotechnology company founded in 1979 that develops a biopharmaceutical gene expression platform based on the fungus Thermothelomyces heterothallica, named C1. This innovative technology enables the development and manufacture of low-cost proteins for biologic vaccines and drugs. The C1 platform aims to speed up dev... Read More
